Deregulation of Fragile X-related protein 1 by the lipodystrophic lamin A p.R482W mutation elicits a myogenic gene expression program in preadipocytes
- PMID: 24108105
- DOI: 10.1093/hmg/ddt509
Deregulation of Fragile X-related protein 1 by the lipodystrophic lamin A p.R482W mutation elicits a myogenic gene expression program in preadipocytes
Abstract
The nuclear lamina is implicated in the regulation of various nuclear functions. Several laminopathy-causing mutations in the LMNA gene, notably the p.R482W substitution linked to familial partial lipodystrophy type 2 (FPLD2), are clustered in the immunoglobulin fold of lamin A. We report a functional association between lamin A and fragile X-related protein 1 (FXR1P), a protein of the fragile X-related family involved in fragile X syndrome. Searching for proteins differentially interacting with the immunoglobulin fold of wild-type and R482W mutant lamin A, we identify FXR1P as a novel component of the lamin A protein network. The p.R482W mutation abrogates interaction of FXR1P with lamin A. Fibroblasts from FPLD2 patients display elevated levels of FXR1P and delocalized FXR1P. In human adipocyte progenitors, deregulation of lamin A expression leads to FXR1P up-regulation, impairment of adipogenic differentiation and induction of myogenin expression. FXR1P overexpression also stimulates a myogenic gene expression program in these cells. Our results demonstrate a cross-talk between proteins hitherto implicated in two distinct mesodermal pathologies. We propose a model where the FPLD2 lamin A p.R482W mutation elicits, through up-regulation of FXR1P, a remodeling of an adipogenic differentiation program into a myogenic program.
Similar articles
-
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks.Hum Mol Genet. 2018 Apr 15;27(8):1447-1459. doi: 10.1093/hmg/ddy055. Hum Mol Genet. 2018. PMID: 29438482
-
Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2162-71. doi: 10.1161/ATVBAHA.113.301933. Epub 2013 Jul 11. Arterioscler Thromb Vasc Biol. 2013. PMID: 23846499
-
The p.R482W substitution in A-type lamins deregulates SREBP1 activity in Dunnigan-type familial partial lipodystrophy.Hum Mol Genet. 2015 Apr 1;24(7):2096-109. doi: 10.1093/hmg/ddu728. Epub 2014 Dec 18. Hum Mol Genet. 2015. PMID: 25524705
-
Nuclear envelope-related lipodystrophies.Semin Cell Dev Biol. 2014 May;29:148-57. doi: 10.1016/j.semcdb.2013.12.015. Epub 2013 Dec 30. Semin Cell Dev Biol. 2014. PMID: 24384368 Review.
-
Laminopathies and lamin-associated signaling pathways.J Cell Biochem. 2011 Apr;112(4):979-92. doi: 10.1002/jcb.22992. J Cell Biochem. 2011. PMID: 21400569 Review.
Cited by
-
Itm2a silencing rescues lamin A mediated inhibition of 3T3-L1 adipocyte differentiation.Adipocyte. 2017 Oct 2;6(4):259-276. doi: 10.1080/21623945.2017.1362510. Epub 2017 Sep 5. Adipocyte. 2017. PMID: 28872940 Free PMC article.
-
Adipocyte-Specific Deletion of Lamin A/C Largely Models Human Familial Partial Lipodystrophy Type 2.Diabetes. 2021 Sep;70(9):1970-1984. doi: 10.2337/db20-1001. Epub 2021 Jun 4. Diabetes. 2021. PMID: 34088712 Free PMC article.
-
The Cutting Edge: The Role of mTOR Signaling in Laminopathies.Int J Mol Sci. 2019 Feb 15;20(4):847. doi: 10.3390/ijms20040847. Int J Mol Sci. 2019. PMID: 30781376 Free PMC article. Review.
-
Molecular and Mechanobiological Pathways Related to the Physiopathology of FPLD2.Cells. 2020 Aug 23;9(9):1947. doi: 10.3390/cells9091947. Cells. 2020. PMID: 32842478 Free PMC article. Review.
-
Spatial control of nucleoporin condensation by fragile X-related proteins.EMBO J. 2020 Oct 15;39(20):e104467. doi: 10.15252/embj.2020104467. Epub 2020 Jul 24. EMBO J. 2020. PMID: 32706158 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous